Hyloris Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.78	23.59	30.41	33.46	50.01
Short-Term Investments	0.49	0.56	0.5	10.47	0.53
Cash & Short-Term Investments	14.27	24.15	30.91	43.93	50.54
Cash Growth	-40.92%	-21.86%	-29.64%	-13.09%	-21.53%
Accounts Receivable	5.15	4.86	3.57	4.13	2.32
Other Receivables	0.36	0.51	0.24	-	-
Receivables	5.52	5.37	3.81	4.13	2.32
Inventory	0.05	-	-	-	-
Prepaid Expenses	0.13	0.19	0.59	1.75	1.1
Other Current Assets	-0	-	-	-	-
Total Current Assets	19.96	29.71	35.31	49.8	53.96
Property, Plant & Equipment	1.69	1.99	2.15	1.06	0.3
Long-Term Investments	3.54	3.75	4.8	4.95	4.53
Other Intangible Assets	5.69	1.76	3.83	1.81	1.85
Long-Term Accounts Receivable	2.48	2.05	1.59	1.31	1.71
Long-Term Deferred Charges	-	2.08	-	1.68	1.09
Other Long-Term Assets	0	-	-	0.12	-
Total Assets	33.36	41.34	47.68	60.73	63.44
Accounts Payable	4.7	3.17	3.2	2.3	2.62
Accrued Expenses	-	0.26	0.12	0.07	0.08
Current Portion of Long-Term Debt	-	0.05	-	-	8.62
Current Portion of Leases	0.36	0.28	0.24	0.14	0.07
Current Income Taxes Payable	-	-	-	-	0.35
Current Unearned Revenue	-	-	0.01	-	-
Other Current Liabilities	0.08	3.41	3.2	3.26	3.25
Total Current Liabilities	5.13	7.16	6.76	5.77	14.98
Long-Term Debt	-	0.05	-	-	-
Long-Term Leases	1.25	1.44	1.51	0.75	0.11
Other Long-Term Liabilities	0.5	0.54	0.34	0.3	0.3
Total Liabilities	6.88	9.19	8.61	6.82	15.39
Common Stock	0.14	0.14	0.14	0.14	0.13
Additional Paid-In Capital	121.51	121.51	121.51	121.51	103.69
Retained Earnings	-92.8	-86.47	-80.76	-65.38	-54.81
Comprehensive Income & Other	-2.37	-3.04	-1.82	-2.36	-0.96
Total Common Equity	26.48	32.14	39.07	53.91	48.06
Shareholders' Equity	26.48	32.14	39.07	53.91	48.06
Total Liabilities & Equity	33.36	41.34	47.68	60.73	63.44
Total Debt	1.61	1.82	1.75	0.89	8.79
Net Cash (Debt)	12.66	22.34	29.15	43.04	41.75
Net Cash Growth	-43.33%	-23.39%	-32.27%	3.09%	-25.39%
Net Cash Per Share	0.46	0.80	1.04	1.58	1.62
Filing Date Shares Outstanding	27.73	28	28	28	25.83
Total Common Shares Outstanding	27.73	28	28	28	25.83
Working Capital	14.83	22.55	28.55	44.03	38.98
Book Value Per Share	0.95	1.15	1.40	1.93	1.86
Tangible Book Value	20.79	30.39	35.24	52.1	46.2
Tangible Book Value Per Share	0.75	1.09	1.26	1.86	1.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.